Azithromycin mass treatment for trachoma control: risk factors for non-participation of children in two treatment rounds.

• Main Authors: Elizabeth N Ssemanda (Author), Joshua Levens (Author), Harran Mkocha (Author), Beatriz Munoz (Author), Sheila K West (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Persistent non-participation of children in mass drug administration (MDAs) for trachoma may reduce program impact. Risk factors that identify families where participation is a problem or program characteristics that foster non-participation are poorly understood. We examined risk factors for househ...